×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RNA – avidity biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
02:02 pm
rna
Avidity Biosciences, Inc. (RNA): A Bull Case Theory [Yahoo! Finance]
Low
Report
Avidity Biosciences, Inc. (RNA): A Bull Case Theory [Yahoo! Finance]
11/21
05:30 pm
rna
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-WTRG, RNA, FIZN, and TCBX
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-WTRG, RNA, FIZN, and TCBX
11/20
05:22 am
rna
Novartis sees sales boost from key cancer drugs [Yahoo! Finance Canada]
Low
Report
Novartis sees sales boost from key cancer drugs [Yahoo! Finance Canada]
11/20
05:13 am
rna
Novartis targets 5%-6% annual sales growth until 2030 on key cancer drugs [CNBC]
Low
Report
Novartis targets 5%-6% annual sales growth until 2030 on key cancer drugs [CNBC]
11/19
09:13 am
rna
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
Low
Report
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
11/12
08:05 am
rna
Avidity Biosciences (NASDAQ:RNA) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Avidity Biosciences (NASDAQ:RNA) had its "hold" rating reaffirmed by analysts at Cowen Inc.
11/11
08:08 am
rna
Avidity Biosciences (NASDAQ:RNA) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $72.00 price target on the stock.
Low
Report
Avidity Biosciences (NASDAQ:RNA) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $72.00 price target on the stock.
11/10
04:58 pm
rna
Avidity Biosciences GAAP EPS of -$1.27 misses by $0.16, revenue of $12.48M [Seeking Alpha]
Low
Report
Avidity Biosciences GAAP EPS of -$1.27 misses by $0.16, revenue of $12.48M [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/24
05:09 pm
rna
Form PREM14A Avidity Biosciences, For: Nov 24
Low
Report
Form PREM14A Avidity Biosciences, For: Nov 24
11/20
03:21 pm
rna
Form DEFA14A Avidity Biosciences,
Low
Report
Form DEFA14A Avidity Biosciences,
11/14
04:17 pm
rna
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
12:21 pm
rna
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Low
Report
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/14
11:58 am
rna
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: JANUS HENDERSON GROUP PLC
11/10
04:31 pm
rna
Form DEFA14A Avidity Biosciences,
Low
Report
Form DEFA14A Avidity Biosciences,
11/10
04:13 pm
rna
Form 10-Q Avidity Biosciences, For: Sep 30
Low
Report
Form 10-Q Avidity Biosciences, For: Sep 30
11/10
04:07 pm
rna
Form 8-K Avidity Biosciences, For: Nov 10
Low
Report
Form 8-K Avidity Biosciences, For: Nov 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: